Evolution of Atopic Dermatitis in the 21st Century (eBook)
VII, 381 Seiten
Springer Singapore (Verlag)
978-981-10-5541-6 (ISBN)
This comprehensive guide offers a state-of-the-art overview of basic and clinical aspects of atopic dermatitis (AD).
The name 'atopic dermatitis' was first used in 1933, and Drs. Lewis Webb Hill and Marion B. Sulzberger presented their report 'Evolution of atopic dermatitis' in 1935. Their observations accurately forecasted the contemporary issues in the management of the condition, such as the conclusions that should be drawn from our understanding of the pathogenesis of AD, and the use of steroids as the main treatment. Several aggravating factors have recently been identified, and these also need to be addressed.
In this context, the expert contributors to this book describe and discuss the evolution of atopic dermatology from Sulzberger's era to the present day, including clinical manifestations, etiopathology and treatment. In addition, it explores skin care intervention, the role of microbiom and GWAS studies, and presents unique, previously unpublished cohort studies.It provides insights into the dynamic changes in AD since Sulzberger introduced topical steroids for its treatment. It is a valuable resource for dermatologists, medical practitioners and researchers who are interested in atopic dermatology.
Dr. Ichiro Katayama,
Dermatology
Department of Integrated Medicine
Graduate School of Medicine
Osaka University
Dr. Hiroyuki Murota,
Dermatology
Department of Integrated Medicine
Graduate School of Medicine
Osaka University
Dr. Takahiro Satoh,
Department of Dermatology,
National Defense Medical College
This comprehensive guide offers a state-of-the-art overview of basic and clinical aspects of atopic dermatitis (AD).The name "e;atopic dermatitis"e; was first used in 1933, and Drs. Lewis Webb Hill and Marion B. Sulzberger presented their report "e;Evolution of atopic dermatitis"e; in 1935. Their observations accurately forecasted the contemporary issues in the management of the condition, such as the conclusions that should be drawn from our understanding of the pathogenesis of AD, and the use of steroids as the main treatment. Several aggravating factors have recently been identified, and these also need to be addressed.In this context, the expert contributors to this book describe and discuss the evolution of atopic dermatology from Sulzberger's era to the present day, including clinical manifestations, etiopathology and treatment. In addition, it explores skin care intervention, the role of microbiom and GWAS studies, and presents unique, previously unpublished cohort studies. It provides insights into the dynamic changes in AD since Sulzberger introduced topical steroids for its treatment. It is a valuable resource for dermatologists, medical practitioners and researchers who are interested in atopic dermatology.
Dr. Ichiro Katayama,DermatologyDepartment of Integrated MedicineGraduate School of MedicineOsaka University Dr. Hiroyuki Murota,DermatologyDepartment of Integrated MedicineGraduate School of MedicineOsaka University Dr. Takahiro Satoh,Department of Dermatology, National Defense Medical College
Part 1. Introduction 1.- History and definition Part 2. Epidemiology 2.- Epidemiology of Childhood AD in Japan 3.- Epidemiology of Childhood AD in Asican countries 4.- Retrospective cohort study in Adlescent AD Part 3. Genetics 5.- GWAS study in Japanese AD Part 4. Etiopathology 6.- Etiopathology of AD from Japanese studies 7.- Non-immunological aspect:Barrier 8.- Immunological aspect: Th2/Mast cell 9.- Immunological aspect: DC/ILC 10.- Cytokine network 11.- Itch and psychiatric aspect 12.- Sweat 13.- Microbiom 14.- Stress Part 5. Classification 15.- Classification (Intrinsic & Extrinsic type) Part 6. Clinical manifestations 16.- Infantile and childhood AD 17.- Adult type AD 18.- Senile AD 19.- Differential Diagnosis Part 7. Diagnosis 20.- Diagnosis and Japanese guideline Part 8. Management 21.- Drug therpay: Ointment 22.- Drug therpay: Systemic 23.- Skin care and intervention 24.- Approach for gaggravating factors 25.- WPAI 26.- New and future therapies Part 9. Complications 27.- Pollenopsis 28.- Food Allergy 29.- Asthma Part 10. Clinical questions 30.- Clinical questions.
Erscheint lt. Verlag | 6.12.2017 |
---|---|
Zusatzinfo | VII, 381 p. 92 illus., 69 illus. in color. |
Verlagsort | Singapore |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie |
Schlagworte | Cytokine • GWAS studies • Microbiom • Skin care intervention • Steroid |
ISBN-10 | 981-10-5541-6 / 9811055416 |
ISBN-13 | 978-981-10-5541-6 / 9789811055416 |
Haben Sie eine Frage zum Produkt? |
Größe: 12,4 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich